Vision 2020: eliminating preventable blindness

Article

We speak with Ivo Kocur of the World Health Organization who tells us how Vision 2020 is helping to reduce avoidable blindness in children around the world.

VISION 2020: The Right to Sight is the joint Global Initiative of the WHO and the International Agency for the Prevention of Blindness (IAPB), which includes an international coalition of non-governmental organisations (NGOs), professional associations, eye care institutions and corporations. With help from VISION 2020, these member organizations run projects all around the world to help improve eye care services to those who most need them. For this year's World Sight Day (11th October) the initiative is raising awareness of avoidable blindness in children and this month sees the launch of its "VISION for Children"1 report, which outlines some of the projects that have been making an impact around the world and aims to draw attention to the work that still needs to be done.

Europe is not guilt-free

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.